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Abstract
Background: Kidney transplant improves patients’ survival and quality of life. Worldwide, concern about the
equality of access to the renal transplant wait-list is increasing. In Iran, patients have the choice to be placed on
either the living or deceased-donor transplant wait-list.
Methods: This was a prospective study performed on 416 kidney transplant recipients (n = 217 (52.2%) from living
donors and n = 199 (47.8%) from deceased donors). Subjects were recruited from four referral kidney transplant
centers across Tehran, Iran, during 2016–2017. The primary outcome was to identify the psycho-socioeconomic
factors influencing the selection of type of donor (living versus deceased). Secondary objective was to compare the
outcomes associated with each type of transplant. The impact of psycho-socioeconomic variables on selecting type
of donor was evaluated by using multiple logistic regression and the effect of surgical and non-surgical variables on
the early post-transplant creatinine trend was assessed by univariate repeated measure ANOVA.
Results: Based on standardized coefficients, the main predictors for selecting living donor were academic
educational level (adjusted OR = 3.25, 95% CI: 1.176–9.005, p = 0.023), psychological status based on general health
questionnaire (GHQ) (adjusted OR = 2.46, 95% CI: 1.105–5.489, p = 0.028), and lower monthly income (adjusted OR =
2.20, 95% CI: 1.242–3.916, p = 0.007). The waiting time was substantially shorter in patients who received kidneys
from living donors (p < 0.001). The early post-transplant creatinine trend was more desirable in recipients of living
donors (β = 0.80, 95% CI: 0.16–1.44, p-value = 0.014), patients with an ICU stay of fewer than five days (β = − 0.583,
95% CI: − 0.643- -0.522, p-value = < 0.001), and those with less dialysis duration time (β = 0.016, 95% CI: 0.004–0.028,
p-value = 0.012). Post-operative surgical outcomes were not different across the two groups of recipients (p = 0.08),
however, medical complications occurred considerably less in the living-donor group (p = 0.04).
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Conclusion: Kidney transplant from living donors was associated with shorter transplant wait-list period and better
early outcome, however, inequality of access to living donors was observed. Patients with higher socioeconomic
status and higher level of education and those suffering from anxiety and sleep disorders were significantly more
likely to select living donors.
Keywords: Deceased donor, Living donor, Kidney transplant, Psychologic status, Socioeconomic
Introduction
Currently, there is a global concern regarding inequality
of access to the renal transplant waiting list [1]. Socio-
economic disparities influence the access to the kidney
transplant wait-list in different parts of the world [1, 2].
In the United Kingdom and the USA, access to the
transplant waiting list is limited for deprived patients,
while in France, patients with a low socioeconomic sta-
tus have an equal access [3–5]. Due to national insur-
ance policies in Iran, complete cost coverage is not
feasible for every patient, thus patients’ socioeconomic
status plays an important role in donor type selection.
In Iran, patients in need of kidney transplants are
placed on two separate wait-lists, based on the type of
donor they select, living versus deceased donors. Thus
far, studies have provided evidence that the outcome of
living-donor transplant is superior to receiving kidneys
from deceased donors [6–9]. This has led to the increas-
ing attention and desire for recipients to opt for living
unrelated donor transplants.
Several factors contribute to this preference including
psychological and socioeconomic factors. Among psy-
chological variables, anxiety and depression pose unique
challenges in the course and prognosis of a disease, as
well as its management [10–14]. The relatively prevalent
coexistence of anxiety and depressive disorders with
chronic medical conditions has diverse clinical conse-
quences on treatment-seeking patterns and management
strategies [15, 16]. Considering the fact that kidney
transplant candidates have to wait for a considerably
long time before receiving a graft, this anticipation
makes them prone to psychiatric issues such as depres-
sion and anxiety [17–19].
Although Iran was the first country to establish a
living unrelated donor program in 1988 and living kid-
ney donation has been performed frequently since then,
a multicenter analysis comparing the psycho-
socioeconomic status of recipients of living and deceased
donors is not yet available [20–22]. Moreover, although
previous studies have shown the necessity of psycho-
social screening in patients awaiting transplant for
selecting the best potential recipients, there is lack of
data regarding the role of psycho-socioeconomic factors
on selecting the best type of donor [23]. Thus, the pri-
mary objective of this study was to investigate psycho-
socioeconomic factors influencing patients’ decision of
choosing type of donor in Iran. We also assessed the
early outcomes associated with each type of transplant.
Objectives
The primary outcome of this study was to identify the
psychological and socioeconomic factors which influence
the selection of type of donor (living versus deceased).
The secondary objectives were to compare the early
medical and surgical outcomes associated with each type
of transplant, identify predictive factors of early post-
transplant creatinine trend (as a marker of kidney func-
tion) and also estimate the mean waiting time for each
type of kidney transplant while on the transplant wait-
list.
Methods
Design and setting
This was a prospective cohort study conducted on pa-
tients undergoing kidney transplant regardless of eti-
ology. Patients were recruited from one of the four
transplant centers across Tehran including; Labbafinejad
hospital, Baqiatallah hospital, Sina hospaital and Mod-
arres hospital, during 2016–2017. Selection of hospitals
was based on the following criteria:
 The center had to be a referral center located in
Tehran, Iran.
 The center had to be a university hospital affiliated
to one of the medical universities of Tehran, Iran.
 The staff of the center had to be willing to
participate in this study and cooperate in sample
collection.
Study participants
Eligible subjects included patients aged ≥18 years old re-
ceiving a kidney transplant during 2016–2017, in one of
the four centers mentioned above. A total of 416 recipi-
ents including 217 patients (52.2%) receiving grafts from
living donors and 199 (47.8%) receiving deceased-donor
transplants were included. The sampling approach was
based on a three-month pilot study performed before
the initiation of the actual study with the aim to estimate
the number of transplants performed in each center and
determine the dominant type of transplantation
Basiri et al. International Journal for Equity in Health           (2020) 19:79 Page 2 of 11
(deceased vs living) in that center. Then, based on prob-
ability proportional to size (PPS) sampling, the number
of subjects required from each center was calculated. In
the next step, sample recruitment started with both
types of transplants. When the number of samples of the
dominant type of transplant (in each specific center)
reached approximately half of the required total sample
size, no more samples of this type of transplant were in-
cluded and recruitment would continue with the less
frequent type of donor until the total sample size was
reached. This ensured that within a particular time-
frame, a proportionate number of living and deceased-
donor transplant recipients would be included without
intentionally or non-intentionally excluding any cases.
Also, the adjustment of the proportion of living and de-
ceased kidney transplant recipients allowed for a more
reliable comparison.
Data collection
Medical files and questionnaires were used to collect
demographic, psycho-socioeconomic, and clinical data of
patients before kidney transplant. Data regarding post-
transplant clinical outcome of patients (medical and sur-
gical) was collected by an independent investigator on
day 1, 3, 5, 7, and 11 after transplant and eventually on
the day of discharge based on history taking, physical
examination, lab data, imaging and medical records. The
indicators of socioeconomic position included employ-
ment status, health insurance, financial support, pre-
dialysis income and education level of recipients one
year before dialysis start. Time to kidney transplant was
defined as time from placement on the waiting list to
the date of the transplant. Income was calculated as in-
dividual (after-tax) disposable income including from
work and benefits and was categorized according to the
consensus of the Iranian Ministry of Cooperative, Labor,
and Social Welfare. Financial support was considered as
any financial assistance from family, relatives, or non-
governmental organizations.
The translated General Health Questionnaire-28
(GHQ-28) was used for assessing mental symptoms and
psychosocial well-being of the recipients [24]. According
to Social Support Questionnaire (SSQ), three different
source of support including family, friends, and signifi-
cant others were evaluated [25]. Also, the translated 36-
Item Short Form Health Survey questionnaire (SF-36)
was applied to evaluate health-related quality of life [26].
Validity and reliability of the Persian version of these
questionnaires has been approved in the Iranian
population [27, 28].
Statistical analysis
Continuous variables were presented as mean (standard
deviation) and categorical variables were reported as
frequencies (percentage). The independent t-test or
Mann-Whitney were used to examine the association
between quantitative variables, and Chi-Square or Fish-
er’s Exact test were used for assessing categorical vari-
ables. The impact of psycho-socioeconomic variables on
selecting the type of donor were evaluated using the
multiple logistic regression with backward approach. Re-
sults are reported as odds ratio (OR) with 95% confi-
dence interval (CI) and p-values. Also, the importance of
variables was determined by computing the standardized
coefficient. Univariate repeated measure ANOVA
assessed the effect of surgical and non-surgical variables
on the early post-transplant creatinine trend. Subse-
quently, variables with a p-value less than 0.05 entered
the multivariable generalized estimating equation (GEE)
model. Finally, to identify predictive factors on the dif-
ference between serum creatinine before transplant and
on the day of discharge, multivariate linear regression
analysis was performed. All statistical analysis was per-
formed using the SPSS software version 14.0 (IBM,
Chicago, Illinois, USA) and also the ‘reghelper’ package
in R software. P-value less than 0.05 was considered sta-
tistically significant.
Ethical approval
Written informed consent was obtained from partici-
pants before being enrolled in the study. The Ethics
Committee of the Urology and Nephrology Research
Center of Shahid Beheshti University of Medical
Sciences (ethics code: UNRC.SBMU.931223.1) approved
this study.
Results
Analysis was conducted on 416 recipients. Among the
total participants, 68% (n = 248) were male. There was
no statistically significant difference between the two
groups of recipients in terms of gender (p = 0.34). The
mean age of the patients transplanted with living and de-
ceased donors was 42.56 (SD = 15.87) and 40.45 (SD =
16.0) years old, respectively (p = 0.13). The mean
duration of dialysis was 14.7 (SD = 17.1) months in re-
cipients of living and 17.9 (SD = 22.6) months in
recipients of deceased donors (p = 0.11). Also, the mean
wait-list period for kidney transplant was significantly
shorter in recipients of living compared to deceased kid-
ney donors (7.05 vs. 11.27 months, p < 0.001).
Socioeconomic and psychological characteristics of the
recipients
As shown in Table 1, recipients’ ethnicity, academic level
of education, employment status, and monthly income
were found to significantly influence the choice of
selecting living or deceased donors (p = 0.008, 0.002,
0.002, < 0.001, respectively). Regarding the four main
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areas covered by the GHQ-28 questionnaire [24], anxiety
and insomnia were reported to be higher among recipi-
ents of living donors (p = 0.044), while more patients re-
ceiving transplants from deceased donors suffered from
depression symptoms (p = 0.045). Among the two dis-
tinct concepts of physical and mental health measured
by the SF-36 questionnaire [29], there was no significant
difference regarding the physical component summary
(PCS) and the mental component summary (MCS) be-
tween living or deceased donor recipients (p = 0.435 and
p = 0.788, respectively). Also, there were no difference
between social support of the family, friends and signifi-
cant others in the two groups of recipients based on the
SSQ questionnaire. Table 1 shows results in detail.
The results of unadjusted analyses to determine pre-
dictive factors of donor type selection are presented in
supplementary Table 1. Also, Table 2 presents the
Table 1 Demographic, psycho-socioeconomic and clinical
characteristics of recipients based on living or deceased donor
Living
(n = 217)
N (%)
Deceased
(n = 199)
N (%)
p value
Age (years) §
mean (SD) 42.56 (15.87) 40.45 (16.00) .13
Gender†
Male 153 (70.5) 131 (65.8) .34
Female 64 (29.5) 68 (34.2)
Ethnicity† .008
Fars 121 (55.7) 128 (64.32)
Turk 43 (19.81) 40 (20.1)
Kurd 21 (9.67) 5 (2.51)
Arab 12 (5.52) 7 (3.51)
Lur 6 (2.76) 11 (5.52)
Other 14 (6.54) 8 (7.54)
Education‡ .002
Illiterate 28 (13.3) 36 (18.7)
Elementary or high school 60 (28.6) 57 (29.5)
Diploma 71 (33.8) 80 (41.5)
Academic degree 51 (24.3) 20 (10.4)
Not declared 7 (3.22) 6 (3.01)
Employment‡ .002
Full time 58 (29.7) 28 (15.6)
Part time 16 (8.2) 19 (10.6)
Self employed 22 (11.3) 10 (5.6)
Unemployed 66 (33.8) 89 (49.7)
Retired 30 (15.4) 27 (15.1)
Disabled person 3 (1.5) 6 (3.4)
Not declared 22 (10.1) 20 (10.0)
Monthly income a ‡ <.001
Low income 81 (43.1) 122 (69.3)
Lower-middle income 82 (43.6) 43 (24.4)
Upper-middle income 25 (13.3) 11 (6.3)
Not declared 29 (13.3) 23 (11.5)
Health Insurance Coverage† .185
Yes 213 (98.2) 191 (96.0)
No 4 (1.8) 8 (4.0)
Financial support b† .486
Yes 83 (45.4) 81 (49.7)
No 100 (54.6) 84 (50.9)
GHQ-28 questionnaire
Somatic symptoms 164 (42.3) 137 (35.3) .162
Anxiety and sleep disorder 168 (43.3) 136 (35.1) .044
Social dysfunction 79 (20.4) 81 (20.9) .290
Depression symptoms 145 (37.5) 147 (37.9) .045
Table 1 Demographic, psycho-socioeconomic and clinical
characteristics of recipients based on living or deceased donor
(Continued)
Living
(n = 217)
N (%)
Deceased
(n = 199)
N (%)
p value
SF-36 questionnaire
mean (SD)
Physical component summary 45.23 (16.24) 46.49 (15.36) .435
Mental component summary 50.95 (25.97) 51.74 (31.16) .788
Social Support Questionnaire †
Family: Low or Moderate 23 (12.5) 27 (13.1) .858
High 161 (87.5) 179 (86.9)
Friends: Low or Moderate 73 (35.4) 60 (32.6) .556
High 133 (64.4) 124 (67.4)
Significant other: Low or Moderate 19 (10.4) 25 (12.4) .552
High 163 (89.6) 177 (87.6)
ESRD causes † .22
Hypertension 77 (37.2) 54 (28.4)
Diabetes Mellitus 26 (12.6) 34 (17.9)
Glomerulonephritis 33 (15.9) 24 (12.7)
Urologic diseases b 23 (11.1) 30 (15.8)
ADPKD 13 (6.3) 20 (10.5)
Others c/Unspecific 45 (21.0) 37(19.4)
ESRD: end stage renal disease, ADPKD: autosomal dominant polycystic
kidney disease
a According to the consensus of the Iranian Ministry of Cooperative, labor, and
social welfare, the minimum wage in 2016–2017 was approximately
10.000.000 Rials per month. Therefore, monthly income of recipients was
divided into these tertiles: low income (monthly income: < 10.000.000 Rials),
lower-middle income (between 10.000.000–20.000.000 Rials) and upper-middle
income (> 20.000.000 Rials)
b Financial support, any financial assistance from family, relatives, or
non-governmental organizations
† Chi Square Test
‡ Mann Whitney
§ Independent sample T test
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results of adjusted analysis in detail. According to ad-
justed analysis, patients with academic education were
almost 3.25 times more likely to select living-donors
compared with the illiterate (OR = 3.41, 95% CI: 1.17–
9.00). There was an almost 2.2 times higher probability
for patients belonging to the lower-middle income group
to select living-donor transplant compared with the low-
income group (OR = 2.2, 95% CI: 1.24–3.91). Moreover,
those with anxiety and sleep disorder were almost 2.46
times more likely to receive living-donor transplant
compared with patients without anxiety and sleep dis-
order (OR = 2.46, 95% CI: 1.10–5.48). However, the
GHQ4 was not significant in multiple logistic analysis, in
unadjusted analysis those with depression symptoms
were almost 40% less likely to receive living-donor trans-
plant compared to those without depression symptoms.
The other unadjusted results was similar and aligned
with adjusted ones.
Clinical outcomes of the kidney transplant
The most common reasons for receiving kidney trans-
plant among the total population were hypertension and
diabetes mellitus (31.5 and 14.4% of all cases, respect-
ively) (Table 1). Post-operative clinical status of all recip-
ients including medical and surgical outcomes and
laboratory tests is presented in Table 3. Post-operative
surgical outcomes were not different across the two
groups of recipients (p = 0.08), however, medical compli-
cations occurred considerably less in the living-donor
group (p = 0.04).
In addition, the effect of non-surgical and surgical var-
iables on the early postoperative creatinine trend was in-
vestigated (Figs. 1 & 2). The multiple GEE model
showed that donor type, duration of dialysis, and ICU
stay of fewer than 5 days were predictive factors of post-
transplant creatinine trend (p = 0.014, 0.012 and < 0.001,
respectively) (Table 4). Also, by performing multiple lin-
ear regression analysis with backward elimination, the
effect of these variables on the difference between serum
creatinine before transplant and on the day of discharge
was explored. In this regard, living-donor kidney trans-
plant was associated with a significantly higher decrease
in post-transplant creatinine levels as compared to de-
ceased donors (p = 0.027). Moreover, patients who were
on peritoneal dialysis experienced less improvement in
post-transplant serum creatinine level compared to
those without a history of dialysis, although this differ-
ence was not statistically significant (p = 0.076).
Discussion
In this study, we investigated the role of patients’ socio-
economic and psychologic condition on electing
Table 2 Multiple logistic regression to determine predictive factors for selecting type of donor
Adjusted
OR
95% CI for OR p-value
Lower Upper
Age 1.012 .992 1.032 .231
Gender (reference: male) .840 .440 1.604 .598
Education (reference: illiterate)
Elementary to high school .936 .427 2.054 .870
Diploma 1.121 .515 2.441 .774
Academic 3.254 1.176 9.005 .023
Monthly income (reference: low income group)
Lower-middle income 2.205 1.242 3.916 .007
Upper-middle income 2.847 .937 8.651 .065
Ethnicity (reference: other) .617 .357 1.066 .084
Financial support (reference: yes) .655 .343 1.249 .199
GHQ2 (reference: without anxiety and sleep disorder) 2.462 1.105 5.489 .028
GHQ4 (reference: without depression symptoms) .702 .335 1.471 .349
SF-36: Physical component summary 1.004 .979 1.029 .780
SF-36: Mental component summary 1.005 .989 1.022 .519
SSQ family (reference: low +med) .684 .190 2.463 .562
SSQ friend (reference: low +med) .950 .469 1.925 .888
SSQ entourage (reference: low +med) .996 .267 3.715 .995
ESRD causes (reference: DM+ HTN) .905 .523 1.566 .722
OR, odds ratio. CI, confidence interval. DM, diabetes mellitus. HTN, hypertension. GHQ, General Health questionnaire. SF-36, Short Form Health Survey-36 SSQ,
Social support questionnaire. ESRD, End stage renal disease
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deceased or living donors. Our results revealed that pa-
tients with higher education and income tended to re-
ceive transplants from living donors more frequently.
This was similar to the majority of studies showing that
access to the kidney transplant waiting list is affected by
higher level of education and socioeconomic deprivation
[2–4, 30–32]. In addition, the results of our study
showed that patients with insomnia and anxiety mostly
desired transplant from living donors while patients with
depression symptoms had a tendency for deceased
donors.
Generally, kidney transplant candidates are prone to
significant psychological distress in the transplant wait-
list period. Previous studies have shown that dialysis pa-
tients anticipating deceased-donor transplant suffer from
anxiety and depression during the transplant wait-list
period [33]. Depression is the most common psychiatric
issue among dialysis patients, mainly due to presence of
multiple stressors in their lives. In one study, patients on
dialysis had stated that while waiting for a transplant,
“they felt their life was on hold and they had a sense of
isolation”, indicating the disparity and depression that
patients on dialysis face [33]. Moreover, waiting for a
deceased-donor transplant is associated with a great deal
of uncertainty since both the timing and the outcome of
the transplant are unknown. The unpredictable results
of this operation can lead to an increased feeling of
stress and anxiety. Regarding living-donor transplant,
since the donor who is either a relative or someone with
an altruistic motive for donating is usually known to the
recipient, somewhat different experiences have been re-
ported [33]. Thus, the dynamic of the relationship be-
tween the donor and the recipient alters the experience
of waiting period. Also, in contrast to deceased-donor
transplant, anticipating transplant from a living-donor is
an active process with a definite outcome [33]. The find-
ings of our study might be justified by the fact that anx-
ious patients desire an immediate transplant with
assured favorable outcome more than others. Although
no study has compared the psychological status of de-
ceased and living-donor recipients before transplant, a
study in Iran showed that depression and anxiety are sig-
nificantly higher in the deceased-donor group after
transplant [34]. There have also been multiple studies
Table 3 Clinical outcome of recipients based on type of donor
Living (n = 217) Deceased (n = 199) p-value‡
n (%) n (%)
Medical events .04
Acute Rejection 13(6) 17 (8.5) .60
ATN 36 (16.6) 54 (27.13) .03
DGF 43 (19.8) 68 (34.17) .004
Arrhythmia 7 (3.22) 7 (3.5) .97
Myocardial infarction 0 (0) 7 (3.5) .02
Pulmonary emboli 3 (1.38) 3 (1.5) .99
Infection 9 (4.15) 6 (3.01) .82
Surgical events .08
Hemorrhage 10 (4.6) 8 (4.02)
Vascular thrombosis 1 (0.46) 5 (2.51)
Ureteral complication 3 (1.38) 3 (1.5)
Surgical site infection 2 (0.92) 3 (1.5)
Lab Data
mean (SD)
Before Transplant→ After Transplant Before Transplant→ After Transplant p-value†
Hb 11.09 (2.28)→ 10.05 (1.72) 11.54 (2.03)→ 9.5 (1.49) .04
WBC 10.40 (14.7)→ 13.92 (13.20) 8.92 (7.26)→ 10.39 (6.59) .22
PLT 184.98 (61.8)→ 189.61 (64.8) 196.95 (99.5)→ 186.36 (66.0) .15
AST 17.47 (9.11)→ 26.60 (16.76) 20.04 (13.62)→ 89.26 (7.65) .03
ALT 19.22 (10.98)→ 43.71 (49.43) 20.86 (18.40)→ 40.91 (62.83) .30
ALP 286.43(226.26)→ 129.40 (16.67) 319.30 (237.57)→ 131.38 (14.90) .19
‡ Chi- square test
† Paired t-test
ESRD, end stage renal disease. ADPKD, autosomal dominant polycystic kidney disease. ATN, acute tubular necrosis. DGF, delayed graft function. Lab data,
laboratory data. Hb, hemoglobin. WBC, white blood cell. PLT, platelet. AST, aspartate aminotransferase. ALT, alanine aminotransferase. ALP, alkaline phosphatase
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comparing psychological status of Iranian patients main-
tained on dialysis with those who have already received
transplants, generally showing a lower anxiety score
among transplant recipients compared to hemodialysis
patients [18, 19].
In general, early post-transplant surgical complications
are classified into three groups: vascular, urologic, and
others. Vascular complications remain the major con-
cern after kidney transplant with a reported incidence of
2 to 15%. In a study by Ayvazoglu Soy et al., the inci-
dence of vascular complications on 2594 kidney
transplants (76% living donors and 24% deceased do-
nors) was 2.1% [35], with the most common complica-
tion being renal artery stenosis (0.6%). In another study
by Ammi et al. on 312 kidney transplants, a vascular
complication rate of 16.0% was reported [36]. Regarding
urologic complications, in a study by Rasiliti and col-
leagues, the prevalence was reported to be 13.1% in 297
deceased kidney transplants [37]. Duty et al. reported
this rate to be approximately 9% [38]. In the present
study, we found the overall rate of surgical complica-
tions to be 9.13%. Postoperative vascular and urologic
Fig. 1 The relation between early postoperative creatinine trend and non-surgical variables*: a. gender (p = 0.734), b. body mass index (p = 0.768),
c. type of dialysis (p = 0.036), d. duration of dialysis (p = 0.004), e. type of donor (p < 0.001), and f. length of ICU stay (p = 0.004)* Serum creatinine
was measured every other day after transplant until discharge
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complications were observed in 5.8 and 1.5% of patients,
respectively. Perhaps the lower rate of urologic compli-
cations in this study was due to the reason that kidney
transplant is solely performed by urologists in Iran while
elsewhere it is mostly performed by general surgeons.
Nevertheless, although post-operative surgical outcomes
were not different across the two groups of recipients in
this study, medical problems were significantly more
common in recipients of deceased donors and a higher
prevalence of delayed graft function, acute tubular
necrosis, and myocardial infarction were seen in these
patients. In a study by Biag et al. performed on 63 pa-
tients with a mean follow-up duration of 14.05 months,
infectious complications were the most common post-
transplant adverse event [39]. There are limited studies
about comparison of early postoperative complications;
however, unscheduled surgical operation, more comor-
bidities, and possibly, less medical care received by re-
cipients of deceased donors might explain the higher
rate of medical complications in this group.
Fig. 2 The relation between early postoperative creatinine trend and surgical variables*: a. techniques of donor nephrectomy (p = 0.001), b. cold
ischemia time (p = 0.021), c. warm ischemia time (p = 0.768), d. method of iliac vessel anastomosis (p = 0.940), and e. ipsilateral or contralateral
placement of the donor kidney (p = 0.740)* Serum creatinine was measured every other day after transplant until discharge
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According to previous studies, risk factors of failure to
reduce early post-transplant serum creatinine level in-
clude gender, BMI, type of dialysis, duration of dialysis,
length of ICU stays, cold and warm ischemia time, and
type of donor [40–42]. Our results showed that living-
donor transplant, ICU stay less than five days, cold is-
chemia time less than sixty minutes and hemodialysis or
no history of dialysis before kidney transplant had a sig-
nificant effect on post-transplant creatinine level. Also,
among recipients of living donors, those who underwent
laparoscopic nephrectomy technique had a better post-
transplant creatinine trend.
Ours study also estimated the waiting time for kidney
transplant in recipients of living donors (7.05 months) to
be significantly less than that of deceased donors (11.27
months). Also, it seemed that living donor transplant in
Iran renders less waiting time compared to other coun-
tries, possibly due to the active living donor program
and high rate of deceased donation. The transplant wait-
ing time in the USA is almost 4.72 years for recipients of
deceased donors and in European countries, this time is
about 2 to 5 years [43]. However, in Norway, where liv-
ing donation is more frequent, the waiting time is 11
months [44].
Although this was not the intention of our study, we
found that hypertension and diabetes mellitus were the
most common factors attributing to end-stage renal dis-
ease (ESRD) in our study population. In line with this
finding, the United States Renal Data System (USRDS)
has reported diabetes mellitus and hypertension as the
major causes of (overall 63%), followed by glomerular
diseases (14%) [45]. However, there was a considerable
difference in the prevalence of urologic etiologies
(13.45%) in our study compared to the data of USRDS.
This may be due to the reason that centers included in
this study were referral transplant centers admitting re-
cipients who are more complicated cases.
There were some limitations to our study:
1. Our socioeconomic data was based on self-reported
questionnaires which may have been inaccurately
reported.
2. The reported psychological status of patients might
be affected by the method of assessment, for
example, results might have been different based on
the person who interviewed the patients
(psychiatrist, psychologist, or unspecialized medical
staff). In this study, the psychological questionnaires
were filled in by an independent blind interviewer
who were medical staff.
3. Some outcomes required a greater number of
patients to reach a more precise conclusion. For
example, vascular complications are not common,
thus for a better comparison of this outcome in the
two groups of recipients, a larger sample size would
have been beneficial [46].
4. Data about human leukocyte antigen (HLA)
matching was missing in our study. Since HLA-
mismatch affects the outcome of transplant and the
post-transplant creatinine trend, we could not reach
a definite conclusion in this regard [40].
Conclusion
This study reveals novel information about the existing
psycho-socioeconomic disparities in Iran in terms of ac-
cess to type of donor and the medical and surgical
Table 4 Multiple analysis on the difference between serum creatinine before transplant and on the day of discharge
GEE model a β CI for β p-value
Type of donor
Living donor .800 .160 1.440 .014
Deceased donor (reference)
Type of dialysis
Peritoneal dialysis .241 −.502 .984 .525
Hemodialysis .399 −.145 .942 .151
No dialysis (reference)
Cold ischemia time .001 −.007 .009 .843
Dialysis duration .016 .004 .028 .012
ICU stay duration −.583 −.643 −.522 < 0.001
Linear regression analysis b, c β CI for β p-value
Living donor (compared to deceased donor) 1.062 0.144 1.998 .027
Peritoneal dialysis (compared to no dialysis) −1.233 −2.593 0.119 .076
Beta: regression coefficient, SE: standard of error
a The dependent variable is creatinine across different time points
b Variable(s) entered in the analysis included: donor type, type of dialysis, duration of dialysis, cold ischemia time and duration of ICU stay
c The dependent variable is difference of serum creatinine before transplant and on the day of discharge
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outcomes associated with each type of transplant. In
summary, higher educational level, higher monthly in-
come, and suffering from anxiety and sleep disorders
(based on the GHQ-28) influenced the choice of select-
ing a living-donor transplant, which came with the bene-
fit of less waiting time and better early post-transplant
creatinine trend. Moreover, although post-operative sur-
gical outcomes were not different across the two groups
of recipients, medical complications occurred consider-
ably less in the living-donor group. However, since the
results associated with outcome of transplant might
change over time in both groups, follow-up of these pa-
tients would be beneficial. Also, future studies to com-
pare the psychological status of these two group of
recipients after transplantation is recommended.
The findings of this comprehensive multicenter study
will provide evidence for policymakers to implement
strategies and specific actions for providing support to
susceptible individuals who are either socioeconomically
or psychologically less advantaged. Hopefully, this will
allow for an equal opportunity to choose between living
or deceased-donor transplant.
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